Pre-market
Loading markets…

Advertisement

Stocks

Will Tilray Inc (TLRY) Beat Estimates Again in Its Next Earnings Report?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:TLRY.TO

Follow TLRY

Photos provided by Pexels

As Tilray Inc prepares to report its next earnings, investors are keenly watching for signs of recovery in a challenging market.

Tilray Inc (TLRY.TO) is set to release its earnings report on October 8, 2026, before the market opens. Investors are particularly interested in how the company will perform against the backdrop of its recent financial history, which has shown a mix of surprises and disappointments. With an EPS consensus of -0.14 and a revenue forecast of $255.35 million, Tilray's upcoming report will be crucial in determining its trajectory in the competitive health care sector, particularly in pharmaceuticals.

Recent earnings trend

Advertisement

Tilray Inc

TLRY.TO

Full stock page →

TLRY.TO

Tilray Inc

Source:WealthAwesomeWealthAwesome
↓ $4.38 (-46.06%)
120 day period
$5.08$7.95$10.82Apr 14Jul 9Oct 2

Market cap

$758.12M

52W high

$32.30

52W low

$5.04

1W change

-10.00%

Beta

1.92

Analyst Price Targets

Based on analyst covering TLRY · as of Oct 5, 2026

📈

Wall Street analysts forecast TLRY stock price to rise 33.5% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$6.85

+33.5% Upside

Previously C$7.74 on Oct 2, 2026

Current Price

C$5.13

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on TLRY's historical volatility

HistoricalForecast68%95%
C$2.60C$3.68C$4.76C$5.84C$6.92C$8.00TodayMay 27Jul 30Oct 2Nov 14Dec 28Feb 9

30-Day Vol

39.3%

Annualized

90-Day Vol

44.2%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$4.29

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$4.83C$4.22 – C$5.54
60 trading daysC$4.55C$3.76 – C$5.52
90 trading daysC$4.29C$3.39 – C$5.43

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Analyst coverage: 4 analyst(s) cover this name; upcoming EPS consensus is available.

Beat estimates in 2 of the last 4 comparable quarter(s).

Fiscal periodReport dateActual EPSEstimateSurprise
2026-05-312026-07-280.05000.2100-76.2%
2026-02-282026-04-010.02000.0700-71.4%
2025-11-302026-01-08-0.0200——
2025-08-312025-10-09-0.0004-0.0300+98.7%
2025-05-312025-07-280.02000.0100+100.0%
2025-02-282025-04-08-0.8700-0.3300-163.6%
-0.8700-0.33000.2100 24-0824-1125-0225-0525-0825-1126-0226-05 Estimate Actual (≥0) Actual (<0) Wealth Awesome

Advertisement

Investor takeaway: With a history of mixed earnings surprises and a current EPS consensus suggesting a loss, investors should approach Tilray's upcoming earnings report with caution, focusing on revenue growth and market positioning.

EPS Consensus at -0.14 with Revenue Growth Projected at 21.9%

Despite a challenging earnings history, Tilray's revenue consensus of $255.35 million reflects a robust anticipated growth of 21.9%, which could provide a buffer against negative EPS figures.

Bull case

Tilray's diverse portfolio across cannabis, beverages, and wellness sectors could help boost revenue growth. Recent reports show record revenues in prior quarters, and if the company can leverage its strengths, it might surprise analysts positively.

Bear case

However, the company has faced significant earnings misses in the past. With an EPS consensus indicating further losses, there's a risk that Tilray may not meet even the lowered expectations, which could negatively impact investor sentiment.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: October 6, 2026
Last Updated: October 6, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement